Literature DB >> 19408045

Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery.

Myong Cheol Lim1, Hyun-Sung Lee, Dae Chul Jung, Ji Young Choi, Sang-Soo Seo, Sang-Yoon Park.   

Abstract

BACKGROUND: The aim of this study was to assess the benefit of video-assisted thoracic surgery (VATS) in pathological diagnosis and intrathoracic cytoreduction of cardiophrenic lymph node (CPLN) and pleural metastasis on computed tomography (CT) in patients with ovarian cancer.
METHODS: We reviewed a database of ovarian cancer patients who underwent VATS from June 2007 to November 2008. The criterion for suspicion of malignancy on CT was either a CPLN with short-axis dimension >5 mm or multinodular pleural thickening. Seven patients with primary ovarian cancer and five patients with recurrent ovarian cancer were identified and evaluated.
RESULTS: Twelve patients met the criterion for suspicious malignancy on CT, with CPLN metastasis and pleural metastasis in nine and five patients, respectively. CPLN metastasis was identified in two of four patients with primary ovarian cancer and in all five patients with recurrent ovarian cancer who had CPLN >5 mm on CT. Pleural metastasis was identified in three of five patients with suspicious pleural metastasis and in one of seven patients without suspicious pleural metastasis on preoperative CT. The median operation time for VATS was 65 min and estimated blood loss was less than 20 ml in all cases. All visible intrathoracic diseases were completely resected without major complications, and VATS did not delay planned treatment.
CONCLUSION: VATS enables the accurate pathological diagnosis and intrathoracic resection of pleural and CPLN metastasis in patients with ovarian cancer with acceptable morbidity. Further studies are needed to confirm the impact of VATS on survival in patients with ovarian cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19408045     DOI: 10.1245/s10434-009-0486-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility.

Authors:  Myong Cheol Lim; Jaeman Bae; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

2.  Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer.

Authors:  Anne-Sophie Bats; Florent Hugonnet; Cyrille Huchon; Chérazade Bensaid; Nadia Pierquet-Ghazzar; Marc Faraggi; Fabrice Lécuru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-23       Impact factor: 9.236

3.  Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer.

Authors:  M Loverro; R Ergasti; C Conte; V Gallitelli; D Nachira; G Scaglione; A Fagotti; G Scambia; V Gallotta
Journal:  Ann Surg Oncol       Date:  2022-01-08       Impact factor: 5.344

Review 4.  Safety and Efficacy of Supradiaphragmatic Lymph Node Dissection in Advanced Ovarian Cancer.

Authors:  Dib Sassine; Chrissy Liu; Yukio Sonoda; Dennis S Chi
Journal:  J Gynecol Surg       Date:  2022-06-13

5.  Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.

Authors:  Renee A Cowan; Jill Tseng; Vijayashree Murthy; Radhika Srivastava; Kara C Long Roche; Oliver Zivanovic; Ginger J Gardner; Dennis S Chi; Bernard J Park; Yukio Sonoda
Journal:  Gynecol Oncol       Date:  2017-09-06       Impact factor: 5.482

6.  Isolated cardiophrenic angle node metastasis from ovarian primary. report of two cases.

Authors:  Mark Ragusa; Jacopo Vannucci; Rosanna Capozzi; Niccolò Daddi; Nicola Avenia; Francesco Puma
Journal:  J Cardiothorac Surg       Date:  2011-01-05       Impact factor: 1.637

7.  Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.

Authors:  Oleg Mironov; Evis Sala; Svetlana Mironov; Harpreet Pannu; Dennis S Chi; Hedvig Hricak
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

8.  Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.

Authors:  Se Ik Kim; Yumi Lee; Myong Cheol Lim; Jungnam Joo; Kibyung Park; Dong Ock Lee; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2015-01-26       Impact factor: 4.401

9.  Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.

Authors:  Se Ik Kim; Myong Cheol Lim; Jiwon Lim; Young Joo Won; Sang Soo Seo; Sokbom Kang; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

10.  Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.

Authors:  C J LaFargue; B T Sawyer; R E Bristow
Journal:  Gynecol Oncol Rep       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.